Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Parexel has completed the separation of its Parexel Informatics and Medical Imaging business.
read more
Friday, December 20, 2013
RPH Pharmaceuticals AB, a subsidiary of Recipharm AB, announces the filing of an application for an infectious disease drug product in a range of European countries. The product has been developed through a partnership with Swedish pharmaceutical ...
read more
Thursday, October 22, 2020
TRI has been awarded a contract to conduct the Randomized Master Protocol for Immune Modulators for Treating COVID-19 study under BARDA in collaboration with the NIH.
read more
The PPD clinical research business of Thermo Fisher Scientific Inc., unveiled a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
read more
Tuesday, December 16, 2025
Lindus Health and Quotient Sciences announced a strategic partnership to enable innovative biotech and pharma sponsors with enhanced patient recruitment for Phase I-IIa clinical studies and a seamless pathway from first-in-human (FIH) to proof-of ...
read more
Pharmatek, a contract development and manufacturing organization supporting the pharmaceutical industry, has made a substantial investment into its spray drying capabilities.
read more
Tuesday, December 03, 2019
Resonant Therapeutics announced the company has entered into an agreement with Janssen with the aim to discover and validate novel tumor and immunological targets.
read more
Perrigo is taking actions to drive substantial profit growth in 2016 and beyond. In total, the actions are expected to add incremental benefits of $175 million when the full run rate of the plan is achieved.
read more
Wednesday, September 07, 2016
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance metabolic disease and oncology research, will be announcing the release of its new translational platforms for metabolic disease ...
read more
Dipharma Francis S.r.l. announced that the Italian Medicines Agency (AIFA) approved the brand-new production line at the cGMP pilot plant suite, located in its facility of Mereto di Tomba (Italy).
read more
Stevanato Group S.p.A. announced a collaboration with Contract Development and Manufacturing Organization (CDMO), Recipharm. Under the agreement, Stevanato Group will lend its 70+ years of manufacturing experience to support the development and ...
read more
Wednesday, February 12, 2020
Catalent has signed an agreement with Zumutor Biologics to manufacture Zumutor’s lead candidate, ZM008, for the treatment of solid tumors.
read more
Wednesday, February 09, 2022
Novasep, a supplier of services and technologies for the life sciences industry, and Sartorius Stedim Biotech, a subgroup of the life science company Sartorius, announced the completion as of February 7, 2022, of the sale of Novasep’s chromatography ...
read more
RLS Radiopharmacies, the only Joint Commission-accredited radiopharmacy network in the U.S., announced it is expanding its business operations with the addition of radiopharmaceutical contract development and manufacturing (rCDMO) services.
read more
Tuesday, November 24, 2020
CPESN USA was announced today as a Federal Pharmacy Partner for the CDC COVID-19 Vaccination Program.
read more